Overcoming paclitaxel resistance in triple-negative breast cancer using a novel barcoding technology

被引：0
|
作者：
Spasic, Milos [1 ,2 ]
Guo, Qiuchen [1 ,2 ]
Maynard, Adam [1 ]
Goreczny, Gregory [1 ,2 ]
Waks, Adrienne
Tolaney, Sara [3 ]
Mittendorf, Elizabeth [2 ,3 ]
McAllister, Sandra [1 ,2 ]
机构：
[1] Harvard Med Sch, Boston, MA USA
[2] Brigham Womens Hosp, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1773
引用
收藏
页数：2
相关论文
共 50 条
  • [1] MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer
    Oudin, Madeleine J.
    Barbier, Lucie
    Schafer, Claudia
    Kosciuk, Tatsiana
    Miller, Miles A.
    Han, Sangyoon
    Jonas, Oliver
    Lauffenburger, Douglas A.
    Gertler, Frank B.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (01) : 143 - 155
  • [2] A novel treatment for triple-negative breast cancer using intrinsic magnetized paclitaxel
    Umemura, Masanari
    Makino, Ayako
    Sato, Itaru
    Feng, Xianfeng
    Oda, Kayoko
    Ohtake, Makoto
    Izuka, Satoshi
    Iwai, Maki
    Matsuo, Kosuke
    Eguchi, Haruki
    Ishikawa, Yoshihiro
    CANCER RESEARCH, 2014, 74 (19)
  • [3] A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy
    Liu, Yuetong
    Hong, Ge
    Mao, Lina
    Su, Zhe
    Liu, Tianjun
    Liu, Hong
    MOLECULES, 2023, 28 (09):
  • [4] Talazoparib nanoparticles for overcoming multidrug resistance in triple-negative breast cancer
    Eskiler, Gamze Guney
    Cecener, Gulsah
    Egeli, Unal
    Tunca, Berrin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (09) : 6230 - 6245
  • [5] Overcoming Chemotherapy Resistance: A Nanomedicine Approach to Triple-Negative Breast Cancer
    Liu, Xueying
    Kinoh, Hiroaki
    Quader, Sabina
    Cabral, Horacio
    Kataoka, Kazunori
    CANCER SCIENCE, 2025, 116 : 1234 - 1234
  • [6] Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance
    Lamballe, Fabienne
    Ahmad, Fahmida
    Vinik, Yaron
    Castellanet, Olivier
    Daian, Fabrice
    Muller, Anna-Katharina
    Kohler, Ulrike A.
    Bailly, Anne-Laure
    Josselin, Emmanuelle
    Castellano, Remy
    Cayrou, Christelle
    Charafe-Jauffret, Emmanuelle
    Mills, Gordon B.
    Geli, Vincent
    Borg, Jean-Paul
    Lev, Sima
    Maina, Flavio
    ADVANCED SCIENCE, 2021, 8 (03)
  • [7] Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer
    Hu, Xichun
    Xu, Binghe
    Cai, Li
    Wang, Zhonghua
    Wang, Biyun
    Zhang, Jian
    Teng, Yuee
    Tong, Zhongsheng
    Pan, Yueyin
    Yin, Yongmei
    Wu, Changping
    Jiang, Zefei
    Wang, Xiaojia
    Lou, Guyin
    Liu, Donggeng
    Feng, Jifeng
    Luo, Jianfeng
    Wu, Jiong
    Shao, Zhimin
    Ragaz, Joseph
    CANCER RESEARCH, 2015, 75
  • [8] Novel Therapies for Triple-Negative Breast Cancer
    Nanda, Rita
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (12) : 799 - 801
  • [9] Research advances and new challenges in overcoming triple-negative breast cancer
    Zong, Yu
    Pegram, Mark
    CANCER DRUG RESISTANCE, 2021, 4 (03) : 517 - 542
  • [10] Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
    Schmid, P.
    Adams, S.
    Rugo, H. S.
    Schneeweiss, A.
    Barrios, C. H.
    Iwata, H.
    Dieras, V.
    Hegg, R.
    Im, S. -A.
    Wright, G. Shaw
    Henschel, V.
    Molinero, L.
    Chui, S. Y.
    Funke, R.
    Husain, A.
    Winer, E. P.
    Loi, S.
    Emens, L. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2108 - 2121
12345